INS and metabolic syndrome: Insulin resistance (IR), a key part of metabolic syndrome (MetS) (5), refers to the diminished ability of an individual’s cells and tissues to respond effectively to insulin (6) and causes a compensatory rise in circulating insulin levels, thereby sustaining normoglycaemia (7).